King Pharmaceuticals KG Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$7.43M— | —— | -$5.05M-107% | $69.93M+17,848% | -$394K— | ||
| $9K-97.0% | $299K+111% | -$2.82M-201% | $2.78M+15,339% | $18K-76.9% | ||
| $1.45M— | —— | —— | —— | $15K— | ||
| -$15.13M+77.0% | -$65.71M-578% | -$9.7M+51.2% | -$19.86M-2,167% | -$876K-307% | ||
| $53M+24.6% | $42.53M+165% | $16.08M-81.8% | $88.33M— | $0— | ||
| $486K— | —— | —— | —— | $0— | ||
| -$486K— | —— | —— | -$40M— | $0— | ||
| $36.83M— | —— | $6.22M-78.7% | $29.13M+3,426% | -$876K-307% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does King Pharmaceuticals generate?
- King Pharmaceuticals (KG) generated -$110.4M in operating cash flow over the trailing twelve months.
- Where does King Pharmaceuticals's cash flow data come from?
- Every line is extracted from King Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
